Innovation and New Technology
EGPAF drives innovation across our programmatic, research and advocacy activities by identifying and adopting new solutions and approaches to achieve our mission quickly, and by efficiently moving innovations to the locations and families most affected by HIV/AIDS.
Changes in the HIV epidemic, population needs, technologies and virus itself challenge us to rapidly adapt our approach and adopt new tools.
Since its founding, EGPAF has embraced game-changing innovations in order to reach our mission and goals: supporting ground-breaking HIV research, introduction and scale-up of adult and pediatric antiretroviral treatment (ART) in low resource settings, provision of services to prevent mother-to-child transmission (PMTCT) of HIV, and decentralization of HIV service delivery, among other program interventions. Our Strategic Plan 2017-2020 emphasizes innovation as a core value that will advance EGPAF’s efforts to effectively end pediatric HIV.
With its extensive service delivery platform, on-the-ground experience, and collaboration with national governments and local partners, EGPAF is well-placed to introduce, evaluate and bring innovation to scale through our programming, while translating evidence into policy and action through targeted advocacy. EGPAF strives to drive innovations that are:
- Impactful: Collecting and scaling up innovative tools and models of care that will fundamentally change policy, practice, and health outcomes
- Catalytic: Producing evidence to inform policy and practice, leading to broader uptake of effective innovations
- Responsive and relevant: Addressing the needs of the women, children and families we support, as well as greater public health questions
- Accessible: Ensuring that innovations are adapted and affordable to our patient populations.